Navigation Links
APSHO Presents Second Annual Mary Pazdur Award for Excellence in Advanced Practice in Oncology to Dr. Jody Pelusi
Date:11/24/2019

At the 7th annual JADPRO Live conference, representatives from the Advanced Practitioner Society for Hematology and Oncology (APSHO) presented the second annual Mary Pazdur Award for Excellence in Advanced Practice in Oncology to Jody Pelusi, PhD, FNP, AOCNP®, of HonorHealth Research Institute in Scottsdale, Arizona.

Dr. Pelusi, a nurse practitioner, educator, and clinical trial sub-investigator with more than 40 years of experience caring for patients with cancer, accepted the award from John A. Gentile, Jr., Chairman of Harborside, and Tina Harris, MS, NP-C, AOCNP®, chair of the APSHO Awards and Recognition Committee, on stage at JADPRO Live. The early afternoon award presentation ceremony included a video highlighting Dr. Pelusi’s work that had been filmed on location in Arizona.

First and foremost a champion for her patients and their families, Dr. Pelusi has been a pioneer in countless “firsts” in Arizona throughout her career. Among other achievements, she co-founded the state’s first oncology chemotherapy course for nurses, developed the first family caregivers training program, developed the first and longest running cancer support group, coordinated the establishment of the oncology services department within Indian Health Services at the Phoenix Indian Hospital, and developed the first mobile program for cancer screening and early detection to individuals in extremely remote rural areas of Arizona.

According to Dr. Pelusi’s nominator for the award, colleague Gayle Jameson, RN, MSN, ACNP-BC, AOCN®, “She literally changed the landscape of access to oncology care in Arizona.”

In her nomination essay, Ms. Jameson, who has been Dr. Pelusi’s colleague for several decades, described her as a caregiver who has “exerted a dynamic influence on advancing the quality of care for patients with cancer and enhancing safe practice, but also has never lost her passion to educate nurses, health care providers, and the community on the unique needs of our dear oncology patients and their families.”

Another of Dr. Pelusi’s colleagues said, “Dr. Pelusi is an excellent mentor, and I have always looked to her for guidance in my own oncology career. I admire her versatility, resourcefulness, and creativity. She has been and continues to be an inspiration for all who have had the pleasure of knowing her and working with her.”

APSHO will begin accepting nominations in December for the third annual Mary Pazdur Award for Excellence in Advanced Practice, which will be presented at the 2020 JADPRO Live conference, October 14-17, in Minneapolis. The winner will receive an honorarium and an all-expenses-paid trip to the 2020 conference, as well as recognition at the meeting and in the Journal of the Advanced Practitioner in Oncology (JADPRO).

About the Mary Pazdur Award for Excellence in Advanced Practice
The annual award, created in honor of Mary Pazdur, RN, MSN, is given to an APSHO member who consistently demonstrates exemplary leadership and outstanding contributions to clinical practice, research, or education in the hematology/oncology field. Ms. Pazdur, who dedicated her professional life as a nurse practitioner to bettering the clinical care and outcomes of cancer patients, was an early champion for the creation of JADPRO, the premier peer-reviewed publication for advanced practitioners and the official journal of APSHO.

To learn more about the Mary Pazdur Award, please visit marypazduraward.com

About APSHO
The Advanced Practitioner Society for Hematology and Oncology (APSHO) is a society for advanced practitioners: nurse practitioners, clinical nurse specialists, physician assistants, pharmacists, and other oncology health-care professionals. The mission of APSHO is to actualize oncology patient care that is high quality, cost effective, and delivered through collaborative practice models by optimizing the role of the advanced practitioner as an integral member of the care team.

About Harborside
Harborside is a medical communications company based in Huntington, New York. It is the publisher of the Journal of the Advanced Practitioner in Oncology (JADPRO), The ASCO Post, JNCCN—Journal of the National Comprehensive Cancer Network, and the Journal of Oncology Practice. Harborside designs educational resources for practicing nurse practitioners, physician assistants, pharmacists, and other advanced practitioners by publishing JADPRO, organizing the JADPRO Live at APSHO conferences, and providing the management services for the Advanced Practitioner Society for Hematology and Oncology.

Read the full story at https://www.prweb.com/releases/apsho_presents_second_annual_mary_pazdur_award_for_excellence_in_advanced_practice_in_oncology_to_dr_jody_pelusi/prweb16741800.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine news :

1. The Center's December Policy Snapshot Examines Medicaid Expansion Moving Forward in Ohio
2. Policy Snapshot Examines Skin Cancer Facts
3. Global snapshot of infectious canine cancer shows how to control the disease
4. Textile Exchange Releases 27 New Material Snapshots
5. The Optical Society Presents Awards to Winners of Its Inaugural ‘Enabled by Optics’
6. San Antonio Alcohol Rehab Presents New Video Regarding Its Services and Consultations for Adults, Adolescents
7. 1 EDI Source Presents the Big Picture in Final Healthcare HIPAA EDI Webinar of 2013
8. Lumosity presents new data on measuring cognitive training improvements
9. The Innovation Institute Presents First Annual Transformation Through Innovation Award to Leaders in Healthcare Design and Construction
10. YogaVibes Presents SmartFLOW Yoga Online With Tiffany Russo
11. Hispanic Federation Presents Seventh Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2020)... ... August 03, 2020 , ... Actuate Therapeutics, Inc. (Actuate), ... first-line advanced pancreatic cancer in a phase 2 study of 9-ING-41, as a ... 9-ING-41 is Actuate’s proprietary small molecule glycogen synthase kinase-3 beta (GSK-3ß) inhibitor ...
(Date:7/31/2020)... ... 2020 , ... National Association of Chain Drug Stores (NACDS) ... nation’s ongoing preparations for the eventual deployment of COVID-19 vaccines: , “By any ... essential component of vaccine deployment. They will need to be part of the ...
(Date:7/22/2020)... ... 2020 , ... Ocean Tomo Transactions, LLC will auction a ... from Brock University for jurisdictions throughout North America, Europe and Asia. Ocean ... the manufacturing processes of novel opioid related compositions for pain management as well ...
(Date:7/18/2020)... , ... July 17, 2020 , ... ... Honorable Mention in the Hermes Creative Awards, was a charitable push put together ... positivity to contrast the news during the pandemic, HMI asked individuals in its ...
(Date:7/18/2020)... (PRWEB) , ... July 17, 2020 , ... ... abundant life, Isagenix International is evolving its brand. While the global ... more holistic approach that supports physical, emotional, and spiritual wellbeing. The company announced ...
Breaking Medicine News(10 mins):
(Date:7/22/2020)... , ... July 22, 2020 , ... ... technology, is proud to announce the addition of Moderna to its growing customer ... rely on its technology for trial disclosure management, patient engagement and study recruitment. ...
(Date:7/18/2020)... ... July 17, 2020 , ... A Perspective essay ... illustrate how implicit bias among psychiatrists and other clinicians can affect patient-clinician communication ... people. The Perspective was authored by researchers at The Fenway Institute and Massachusetts ...
(Date:7/10/2020)... ... ... The team at The Keyhole Heart Clinic have been hard at ... a multitude of user enhancements and streamlined navigation for a more intuitive user experience. ... which will allow patients to find the information they need quickly. Of particular interest ...
Breaking Medicine Technology: